Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
August 7, 2019 4:11 PM 23 min read

RCM Technologies, Inc. Announces Second Quarter Results

by Globe Newswire
Follow

PENNSAUKEN, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care and information technology services, today announced financial results for the thirteen and twenty-six week periods ended June 29, 2019.

RCM Technologies reported revenue of $50.7 million for the thirteen week period ended June 29, 2019 (the current period), a 1.9% decrease as compared to $51.7 million for the thirteen week period ended June 30, 2018 (the comparable prior year period). Gross profit was $12.8 million for the current period, a 0.5% increase as compared to $12.7 million for the comparable prior year period.  The Company experienced GAAP operating income of $2.2 million for the current period, as compared to $0.9 million for the comparable prior year period.  GAAP net income was $1.3 million, or $0.10 per diluted share, for the current period as compared to $0.4 million, or $0.03 per diluted share, for the comparable prior year period.

RCM Technologies reported revenue of $102.3 million for the twenty-six week period ended June 29, 2019 (the current period), a marginal decrease as compared to $102.5 million for the twenty-six week period ended June 30, 2018 (the comparable prior year period). Gross profit was $25.3 million for both periods presented.  The Company experienced GAAP operating income of $3.8 million for the current period, as compared to $2.6 million for the comparable prior year period.  GAAP net income was $2.7 million, or $0.21 per diluted share, for the current period as compared to $1.4 million, or $0.12 per diluted share, for the comparable prior year period.

The Company experienced $1.4 million in severance, professional fees and other charges for both the thirteen and twenty-six week periods ended June 30, 2018.  These charges include severance accrued for the Company's former chief executive officer and related payroll taxes, continuation of certain benefits and professional fees, totaling approximately $0.9 million.  The additional charges of $0.5 million incurred related to transactional financial advisory fees, legal fees associated with defending a frivolous lawsuit with a competitor of the Company, and search fees associated with hiring a senior executive. 

Bradley Vizi, Executive Chairman of RCM Technologies, commented, "Allowing for third-quarter seasonality in our Healthcare segment from summer school closings, we believe we are poised for a strong finish to fiscal 2019 and that we have positioned RCM to demonstrate higher earnings power in 2020."

Kevin Miller, Chief Financial Officer of RCM Technologies, added, "We are pleased with generating $3.1 million in cash flow from operations in the second quarter of 2019. We expect continued strong cash flow through the remainder of the year."

Conference Call
On Thursday, August 8, 2019, RCM Technologies will host a conference call to discuss these results. The call will begin at 10:00 a.m. Eastern Time.  The dial-in number is (866) 403-9129.

Tables to Follow

RCM Technologies, Inc.
Condensed Consolidated Statements of Income
(Unaudited)
 (In Thousands, Except Per Share Amounts)


RCM Technologies, Inc.
Summary Consolidated Selected Balance Sheet Data
 (In Thousands)

RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Unaudited)
(In Thousands)

The following unaudited table presents the Company's GAAP net income measure and the corresponding adjustments used to calculate "EBITDA" and "Adjusted EBITDA" for the thirteen and twenty-six week periods ended June 29, 2019 and June 30, 2018. 

RCM Technologies, Inc. 
Condensed Consolidated Statements of Cash Flows 
(Unaudited) 
(In Thousands)


RCM Technologies, Inc. 
Summary of Selected Income Statement Data 
(Unaudited) 
(In Thousands)





Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsPress Releases
RCMT Logo
RCMTRCM Technologies Inc
$18.610.11%
Overview

About RCM
RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services.  RCM is an innovative leader in the delivery of these solutions to commercial and government sectors.  RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America.  Additional information can be found at www.rcmt.com.

The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements.  These statements often include words such as "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "believe," "plan," "seek," "could," "can," "should," "are confident" or similar expressions.  In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances.  Forward-looking statements include, but are not limited to, those relating to demand for the Company's services, expectations regarding our future revenues and other financial results, our pipeline and potential project wins and our expectations for growth in our business. Such statements are based on current expectations that involve a number of known and unknown risks, uncertainties and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements.  Risk, uncertainties and other factors may emerge from time to time that could cause the Company's actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

 Thirteen Week Periods Ended 
 June 29, 
2019
 June 30, 
2018
 
Revenue$50,705 $51,710 
Cost of services37,902 38,975 
Gross profit12,803 12,735 
Selling, general and administrative10,202 10,076 
Depreciation and amortization of property and equipment325 381 
Severance, professional fees and other charges- 1,371 
Amortization of acquired intangible assets83 17 
Operating income2,193 890 
Other expense, net(483)(388)
Income before income taxes1,710 502 
Income tax expense459 121 
Net income$1,251 $381 
     
Diluted net earnings per share data$0.10 $0.03 
 Twenty-Six Week Periods Ended 
 June 29, 
2019
 June 30, 
2018
 
Revenue$102,300 $102,522 
Cost of services76,980 77,232 
Gross profit25,320 25,290 
Selling, general and administrative20,667 20,497 
Depreciation and amortization of property and equipment640 778 
Severance, professional fees and other charges- 1,371 
Amortization of acquired intangible assets165 34 
Operating income3,848 2,610 
Other expense, net(949)(695)
Income before income taxes2,899 1,915 
Income tax expense185 483 
Net income$2,714 $1,432 
     
Diluted net earnings per share data$0.21 $0.12 
 March 30, 
2019
 December 29, 
2018
 (Unaudited)  
Cash and cash equivalents$868 $482
Accounts receivable, net$58,230 $52,335
Total current assets$63,935 $58,811
Total assets$92,099 $81,510
Total current liabilities$21,824 $23,188
Borrowing under line of credit$30,943 $27,540
Net debt (borrowings less cash)$30,075 $27,058
Total liabilities$61,550 $54,311
Stockholders' equity$30,549 $27,199

The following non-GAAP data, which adjusts for the categories of expenses described below, is a non-GAAP financial measure.  Our management believes that this non-GAAP financial measure is useful information for investors, shareholders and other stakeholders of our Company in gauging our results of operations on an ongoing basis.  We believe that EBITDA and Adjusted EBITDA are performance measures and have provided a reconciliation between net income and EBITDA and Adjusted EBITDA.  Neither EBITDA nor Adjusted EBITDA should be considered as an alternative to net income as an indicator of performance.  In addition, neither EBITDA nor Adjusted EBITDA takes into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP.  These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 Thirteen 
Week Periods Ended
 Twenty-Six
Week Periods Ended
 June 29, 
2019
 June 30, 
2018
 June 29, 
2019
 June 30, 
2018
GAAP net income$1,251 $381 $2,714 $1,432
Income tax expense 459  121  185  483
Interest expense 458  400  887  666
Imputed interest on contingent consideration 48  -  96  -
Depreciation of property and equipment 325  381  640  778
Amortization of acquired intangible assets 83  17  165  34
EBITDA (non-GAAP)$2,624 $1,300 $4,687 $3,393
        
Adjustments       
Severance, professional fees and other charges -  1,371  -  1,371
(Gain) loss on foreign currency transactions (23) (12) (34) 29
Adjusted EBITDA (non-GAAP)$2,601 $2,659 $4,653 $4,793
 Thirteen Week Periods Ended 
 June 29,
2019
  June 30,
2018
 
Net income$1,251  $381 
Adjustments to reconcile net income to cash
  used in operating activities
761  623 
Changes in operating assets and liabilities:     
Accounts receivable353  (82)
Prepaid expenses and other current assets548  276 
Net of transit accounts receivable and payable917  149 
Accounts payable and accrued expenses(639) (213)
Accrued payroll and related costs(345) 1,735 
Right of use assets and liabilities(7) - 
Income taxes payable239  565 
Total adjustments1,827  3,053 
Cash provided by operating activities$3,078  $3,434 
      
Net cash used in investing activities(136) (313)
Net cash used in financing activities(3,743) (3,111)
Effect of exchange rate changes(24) (31)
Decrease in cash and cash equivalents($825) ($21)
 Twenty-Six Week Periods Ended 
 June 29,
2019
 June 30,
2018
 
Net income$2,714 $1,432 
Adjustments to reconcile net income to cash
  used in operating activities
1,494 1,402 
Changes in operating assets and liabilities:    
Accounts receivable(5,911)(6,160)
Prepaid expenses and other current assets658 274 
Net of transit accounts receivable and payable962 (1,094)
Accounts payable and accrued expenses(1,465)(1,425)
Accrued payroll and related costs(1,217)1,665 
Right of use assets and liabilities259 - 
Income taxes payable29 296 
Total adjustments(5,191)(5,042)
Cash used in operating activities($2,477)($3,610)
     
Net cash used in investing activities(238)(613)
Net cash provided by financing activities3,140 1,817 
Effect of exchange rate changes(39)(14)
Increase (decrease) in cash and cash equivalents$386 ($2,420)
 Thirteen Week Period Ended June 29, 2019 
 Engineering Specialty
Health Care
 Information
Technology
  

Consolidated
 
         
Revenue$18,583 $23,370 $8,752 $50,705 
Cost of services13,324 18,057 6,521 37,902 
Gross Profit$5,259 $5,313 $2,231 $12,803 
Gross Profit Margin28.3%22.7%25.5%25.3%
 Thirteen Week Period Ended June 30, 2018 
 Engineering Specialty
Health Care
 Information
Technology
  

Consolidated
 
         
Revenue$21,571 $22,858 $7,281 $51,170 
Cost of services15,934 17,771 5,270 38,975 
Gross Profit$5,637 $5,087 $2,011 $12,735 
Gross Profit Margin26.1%22.3%27.6%24.9%
 Twenty-Six Week Period Ended June 29, 2019 
 Engineering Specialty
Health Care
 Information
Technology
  

Consolidated
 
         
Revenue$37,638 $47,540 $17,122 $102,300 
Cost of services27,682 36,593 12,705 76,980 
Gross Profit$9,956 $10,947 $4,417 $25,320 
Gross Profit Margin26.5%23.0%25.8%24.8%
 Twenty-Six Week Period Ended June 30, 2018 
 Engineering Specialty
Health Care
 Information
Technology
  

Consolidated
 
         
Revenue$42,988 $45,492 $14,042 $102,522 
Cost of services31,658 35,156 10,418 77,232 
Gross Profit$11,330 $10,336 $3,624 $25,290 
Gross Profit Margin26.4%22.7%25.8%24.7%
RCM Technologies, Inc.Tel:  856.356.4500Corporate Contacts:
2500 McClellan AvenueFax: 856.356.4600Bradley S. Vizi
Pennsauken, NJ 08109[email protected]Executive Chairman 
 www.rcmt.comKevin D. Miller
  Chief Financial Officer

RCMT Logo
RCMTRCM Technologies Inc
$18.610.11%
Overview
Comments
Loading...